MA47731A - Inhibiteurs de bêta-sécrétase - Google Patents
Inhibiteurs de bêta-sécrétaseInfo
- Publication number
- MA47731A MA47731A MA047731A MA47731A MA47731A MA 47731 A MA47731 A MA 47731A MA 047731 A MA047731 A MA 047731A MA 47731 A MA47731 A MA 47731A MA 47731 A MA47731 A MA 47731A
- Authority
- MA
- Morocco
- Prior art keywords
- beta
- secretase inhibitors
- secretase
- inhibitors
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Veterinary Medicine (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201762468070P | 2017-03-07 | 2017-03-07 | |
EP17189778 | 2017-09-07 |
Publications (1)
Publication Number | Publication Date |
---|---|
MA47731A true MA47731A (fr) | 2020-01-15 |
Family
ID=61616995
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA047731A MA47731A (fr) | 2017-03-07 | 2018-03-06 | Inhibiteurs de bêta-sécrétase |
Country Status (9)
Country | Link |
---|---|
US (1) | US20190389882A1 (fr) |
EP (1) | EP3592752A1 (fr) |
JP (1) | JP2020509064A (fr) |
KR (1) | KR20190126346A (fr) |
CN (1) | CN110382506A (fr) |
AU (1) | AU2018229723A1 (fr) |
CA (1) | CA3051779A1 (fr) |
MA (1) | MA47731A (fr) |
MX (1) | MX2019010653A (fr) |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AR077277A1 (es) * | 2009-07-09 | 2011-08-17 | Lilly Co Eli | Compuestos de biciclo (1,3)tiazin-2-amina formulacion farmaceutica que lo comprende y su uso para la manufactura de un medicamento util para el tratamiento de la enfermedad de alzheimer |
-
2018
- 2018-03-06 AU AU2018229723A patent/AU2018229723A1/en not_active Abandoned
- 2018-03-06 CA CA3051779A patent/CA3051779A1/fr not_active Abandoned
- 2018-03-06 JP JP2019548451A patent/JP2020509064A/ja active Pending
- 2018-03-06 US US16/489,910 patent/US20190389882A1/en not_active Abandoned
- 2018-03-06 MA MA047731A patent/MA47731A/fr unknown
- 2018-03-06 EP EP18710001.1A patent/EP3592752A1/fr not_active Withdrawn
- 2018-03-06 MX MX2019010653A patent/MX2019010653A/es unknown
- 2018-03-06 KR KR1020197028606A patent/KR20190126346A/ko unknown
- 2018-03-06 CN CN201880016097.1A patent/CN110382506A/zh active Pending
Also Published As
Publication number | Publication date |
---|---|
KR20190126346A (ko) | 2019-11-11 |
US20190389882A1 (en) | 2019-12-26 |
EP3592752A1 (fr) | 2020-01-15 |
MX2019010653A (es) | 2019-10-21 |
CN110382506A (zh) | 2019-10-25 |
JP2020509064A (ja) | 2020-03-26 |
AU2018229723A1 (en) | 2019-08-15 |
CA3051779A1 (fr) | 2018-09-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA54543A (fr) | Inhibiteurs de kif18a | |
MA54550A (fr) | Inhibiteurs de kif18a | |
DK3731771T3 (da) | V462033dk00 | |
DK3612525T3 (da) | Pd-1-/pd-l1-inhibitorer | |
DK3497103T3 (da) | Pyridopyrimdinon-cdk2/4/6-inhibitorer | |
DK3442972T3 (da) | Bromdomænehæmmere | |
MA52812A (fr) | Inhibiteurs de sarm1 | |
DE202018003363U8 (de) | Handgelenkssphygmomanometer | |
CL2018000524S1 (es) | Golilla | |
DK3672976T3 (da) | Bcl-2-hæmmere | |
MA46857A (fr) | Inhibiteurs de magl | |
DK3571192T3 (da) | Jak1-selektive inhibitorer | |
CU20160125A7 (es) | Inhibidores de diacilglicerol aciltransferasa 2 | |
DK3681884T3 (da) | Rad51-inhibitorer | |
MA46860A (fr) | Inhibiteurs de magl | |
DK3351526T3 (da) | Diisopentylterephthalat | |
MA46855A (fr) | Inhibiteurs de magl | |
DK3630744T3 (da) | Pyrazol-magl-inhibitorer | |
MA43367A (fr) | Inhibiteurs de métallo-bêta-lactamases | |
DK3571580T5 (da) | Load-logical-and-shift-guarded-instruktion | |
MA52813A (fr) | Inhibiteurs de sarm1 | |
DK3568655T3 (da) | Rekuperator | |
MA52809A (fr) | Inhibiteurs de sarm1 | |
MA46280A (fr) | Inhibiteurs de la dopamine-b-hydroxylase | |
DK3612237T3 (da) | Genterapi |